NASDAQ:LIFE - Nasdaq - US0021202025 - Common Stock - Currency: USD
Taking everything into account, LIFE scores 2 out of 10 in our fundamental rating. LIFE was compared to 558 industry peers in the Biotechnology industry. LIFE has a bad profitability rating. Also its financial health evaluation is rather negative. LIFE is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -47.62% | ||
ROE | -63.85% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | N/A | ||
Altman-Z | -4.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 6.07 | ||
Quick Ratio | 6.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
1.9
+0.05 (+2.7%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 220.87 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.54 | ||
P/tB | 1.54 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -47.62% | ||
ROE | -63.85% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 432.17% | ||
Cap/Sales | 507.14% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 6.07 | ||
Quick Ratio | 6.07 | ||
Altman-Z | -4.12 |